Paul Stuka

Paul Stuka, listed as senior executive, appears in our data through filings on InspireMD, Inc. shares, published by SEC (Form 4). Between 26 January 2016 and 13 May 2026, the trades on record add up to 23 filings.

On the market, this insider has only ever bought: 15 purchases, €669k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 8 share grants. So far in 2026, the count stands at 4 purchases and no sales.

In size, the median ticket on the buying side is €19k. Relative to company size, the median is 0.18% of market cap (3 purchases with a known value). 7 out of 14 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster.

The record was last updated on 15 May 2026 with an open-market purchase (€9,880) in InspireMD, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.